Judith M. Matthews
2019
In 2019, Judith M. Matthews earned a total compensation of $565.1K as Chief Financial Officer at Iterum Therapeutics plc, a 8% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $62,475 |
|---|---|
| Option Awards | $112,200 |
| Salary | $356,417 |
| Stock Awards | $32,840 |
| Other | $1,161 |
| Total | $565,093 |
Matthews received $356.4K in salary, accounting for 63% of the total pay in 2019.
Matthews also received $62.5K in non-equity incentive plan, $112.2K in option awards, $32.8K in stock awards and $1.2K in other compensation.
Rankings
In 2019, Judith M. Matthews' compensation ranked 11,383rd out of 13,971 executives tracked by ExecPay. In other words, Matthews earned more than 18.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,383 out of 13,971 | 19th |
Division Manufacturing | 4,616 out of 5,701 | 19th |
Major group Chemicals And Allied Products | 1,819 out of 2,200 | 17th |
Industry group Drugs | 1,565 out of 1,886 | 17th |
Industry Pharmaceutical Preparations | 1,157 out of 1,398 | 17th |
Source: SEC filing on May 7, 2020.
Matthews' colleagues
We found two more compensation records of executives who worked with Judith M. Matthews at Iterum Therapeutics plc in 2019.